• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

儿童植入式心律转复除颤器患者发生不适当电击的风险低:单中心经验。

Low Risk of Inappropriate Shock Among Pediatric Patients With an Implantable Cardioverter Defibrillator: A Single Center Experience.

机构信息

Department of Pediatric Cardiology, Schneider's Children Medical Center, Petach-Tikva, Israel.

Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

出版信息

Pediatr Cardiol. 2024 Dec;45(8):1776-1783. doi: 10.1007/s00246-023-03280-0. Epub 2023 Sep 5.

DOI:10.1007/s00246-023-03280-0
PMID:37668692
Abstract

Implantable cardioverter-defibrillators (ICD) are increasingly being used among the pediatric population for indications of both primary and secondary prevention. There is limited long-term data on the outcomes of pediatric patients following ICD implantation. The aim of this study was to investigate the characteristics of this population, burden of appropriate and inappropriate shock and complication rate in a large tertiary pediatric medical center. Included were children under the age of 18 years who underwent ICD implantation and had clinical follow up at our center. Data were retrospectively collected between study period 2005-2020. Primary outcome was the incidence of ICD shock appropriate and inappropriate. Secondary outcome was defining our patient population characteristics. Our cohort included 51 patients who underwent ICD implantation. Mean age at implantation was 10.9 ± 4.7 years and average follow-up time was 67 months. Diagnoses of implanted patients were: 28 (55%) patients with syndromes with risk for sudden death, cardiomyopathy in 14 patients (27%) and congenital heart disease (CHD) in 9 patients (18%). Forty-two (82%) patients had an ICD implanted for secondary prevention after experiencing a life-threatening arrhythmia and 9 (18%) for primary prevention. An endocardial system was implanted in 39 (76%) patients and an epicardial systems in 12 (24%) patients. A total of 20 (39%) patients received appropriate shocks for ventricular fibrillation(VF). 5 patients received inappropriate shocks, 4 due to sinus tachycardia and 1 due to rapidly conducted atrial fibrillation. Those who received an inappropriate shock had a significantly shorter ICD-programmed VF detection cycle length compared to those who did not receive an inappropriate shock (320 ms versus 270 ms, p = 0.062). This single center study demonstrates a high rate of appropriate ICD shocks (39%) and a low rate of inappropriate ICD shocks. Accurate programming of ICD devices in the pediatric population is paramount to avoid inappropriate ICD shocks.

摘要

植入式心律转复除颤器(ICD)在儿科人群中的应用越来越广泛,用于一级和二级预防。关于儿科患者植入 ICD 后的长期结果数据有限。本研究旨在调查该人群的特征、适当和不适当电击的负担以及大型三级儿科医疗中心的并发症发生率。研究对象为在我们中心接受 ICD 植入并进行临床随访的年龄在 18 岁以下的儿童。数据是在 2005 年至 2020 年的研究期间回顾性收集的。主要结果是 ICD 电击的适当和不适当发生率。次要结果是确定我们的患者人群特征。我们的队列包括 51 名接受 ICD 植入的患者。植入时的平均年龄为 10.9±4.7 岁,平均随访时间为 67 个月。植入患者的诊断为:28 名(55%)患者患有有猝死风险的综合征,14 名(27%)患者患有心肌病,9 名(18%)患者患有先天性心脏病(CHD)。42 名(82%)患者因发生危及生命的心律失常而植入 ICD 进行二级预防,9 名(18%)患者因一级预防而植入 ICD。39 名(76%)患者植入心内膜系统,12 名(24%)患者植入心外膜系统。共有 20 名(39%)患者因室颤(VF)接受了适当的电击。5 名患者接受了不适当的电击,其中 4 名是由于窦性心动过速,1 名是由于快速传导的心房颤动。与未接受不适当电击的患者相比,接受不适当电击的患者 ICD 程控的 VF 检测周期长度明显更短(320ms 比 270ms,p=0.062)。这项单中心研究表明,适当的 ICD 电击率较高(39%),不适当的 ICD 电击率较低。在儿科人群中准确编程 ICD 设备对于避免不适当的 ICD 电击至关重要。

相似文献

1
Low Risk of Inappropriate Shock Among Pediatric Patients With an Implantable Cardioverter Defibrillator: A Single Center Experience.儿童植入式心律转复除颤器患者发生不适当电击的风险低:单中心经验。
Pediatr Cardiol. 2024 Dec;45(8):1776-1783. doi: 10.1007/s00246-023-03280-0. Epub 2023 Sep 5.
2
Long-term follow-up of implantable cardioverter-defibrillators in adult congenital heart disease patients: indications and outcomes.成人先天性心脏病患者植入式心脏复律除颤器的长期随访:适应证与结局
Europace. 2017 Mar 1;19(3):407-413. doi: 10.1093/europace/euw076.
3
Transvenous and non-transvenous implantable cardioverter-defibrillators in children, adolescents, and adults with congenital heart disease: who is at risk for appropriate and inappropriate shocks?经静脉和非经静脉植入式心脏复律除颤器在先天性心脏病儿童、青少年和成人中的应用:谁有发生适当和不适当电击的风险?
Europace. 2019 Jan 1;21(1):106-113. doi: 10.1093/europace/euy219.
4
Low Prevalence of Inappropriate Shocks in Patients With Inherited Arrhythmia Syndromes With the Subcutaneous Implantable Defibrillator Single Center Experience and Long-Term Follow-Up.植入式皮下除颤器治疗遗传性心律失常综合征患者的低比例不适当电击:单中心经验和长期随访。
J Am Heart Assoc. 2017 Oct 17;6(10):e006265. doi: 10.1161/JAHA.117.006265.
5
Implantable Cardioverter Defibrillators in Infants and Toddlers: Indications, Placement, Programming, and Outcomes.婴儿和幼儿植入式心脏转复除颤器:适应证、放置、程控和结果。
Circ Arrhythm Electrophysiol. 2022 Feb;15(2):e010557. doi: 10.1161/CIRCEP.121.010557. Epub 2022 Jan 28.
6
Inappropriate ICD shocks in pediatrics and congenital heart disease patients: Risk factors and programming strategies.儿科及先天性心脏病患者不适当的植入式心律转复除颤器电击:危险因素与程控策略
Heart Rhythm. 2015 May;12(5):937-42. doi: 10.1016/j.hrthm.2015.01.028. Epub 2015 Jan 22.
7
Primary prevention implantable cardioverter-defibrillators in hypertrophic cardiomyopathy-Are there predictors of appropriate therapy?肥厚型心肌病患者的一级预防植入式心脏转复除颤器——是否存在合适治疗的预测因素?
Heart Rhythm. 2021 Jan;18(1):63-70. doi: 10.1016/j.hrthm.2020.08.009. Epub 2020 Aug 12.
8
The subcutaneous implantable cardioverter-defibrillator: A tertiary center experience.皮下植入式心脏除颤器:一家三级中心的经验。
Cardiol J. 2019;26(5):543-549. doi: 10.5603/CJ.a2018.0050. Epub 2018 May 2.
9
Effectiveness of subcutaneous implantable cardioverter-defibrillators and determinants of inappropriate shock delivery.皮下植入式心律转复除颤器的有效性及不适当电击发放的决定因素。
Int J Cardiol. 2017 Apr 1;232:176-180. doi: 10.1016/j.ijcard.2017.01.034. Epub 2017 Jan 5.
10
Outcomes of Pediatric Patients With Defibrillators Following Initial Presentation With Sudden Cardiac Arrest.儿科患者在初次出现心搏骤停后植入除颤器的结果。
Circ Arrhythm Electrophysiol. 2021 Feb;14(2):e008517. doi: 10.1161/CIRCEP.120.008517. Epub 2021 Jan 5.

本文引用的文献

1
Clinical Outcomes of Implantable Cardioverter-Defibrillator in Pediatric Patients - A Korean Multicenter Study.小儿患者植入式心脏复律除颤器的临床转归-韩国多中心研究。
Circ J. 2021 Jul 21;85(8):1356-1364. doi: 10.1253/circj.CJ-20-0468. Epub 2021 May 12.
2
Subcutaneous implantable cardioverter defibrillator in children and adolescents: results from the S-ICD "Monaldi care" registry.皮下植入式心律转复除颤器在儿童和青少年中的应用:来自 S-ICD“Monaldi 护理”注册研究的结果。
J Interv Card Electrophysiol. 2022 Mar;63(2):283-293. doi: 10.1007/s10840-021-00966-4. Epub 2021 Mar 11.
3
Outcomes of Pediatric Patients With Defibrillators Following Initial Presentation With Sudden Cardiac Arrest.
儿科患者在初次出现心搏骤停后植入除颤器的结果。
Circ Arrhythm Electrophysiol. 2021 Feb;14(2):e008517. doi: 10.1161/CIRCEP.120.008517. Epub 2021 Jan 5.
4
2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.2020年美国心脏协会/美国心脏病学会肥厚型心肌病患者诊断和治疗指南:美国心脏病学会/美国心脏协会临床实践指南联合委员会报告
Circulation. 2020 Dec 22;142(25):e558-e631. doi: 10.1161/CIR.0000000000000937. Epub 2020 Nov 20.
5
Characteristics and Outcomes of Pediatric Patients Who Undergo Placement of Implantable Cardioverter Defibrillators: Insights From the National Cardiovascular Data Registry.儿科患者植入式心脏复律除颤器的特点和结局:来自全国心血管数据注册中心的见解。
Circ Arrhythm Electrophysiol. 2018 Sep;11(9):e006542. doi: 10.1161/CIRCEP.118.006542.
6
Current Trends in Implantable Cardioverter-Defibrillator Therapy in Children - Results From the JCDTR Database.儿童植入式心脏复律除颤器治疗的现状——来自 JCDTR 数据库的结果。
Circ J. 2018 Dec 25;83(1):52-55. doi: 10.1253/circj.CJ-18-0712. Epub 2018 Oct 20.
7
Transvenous and non-transvenous implantable cardioverter-defibrillators in children, adolescents, and adults with congenital heart disease: who is at risk for appropriate and inappropriate shocks?经静脉和非经静脉植入式心脏复律除颤器在先天性心脏病儿童、青少年和成人中的应用:谁有发生适当和不适当电击的风险?
Europace. 2019 Jan 1;21(1):106-113. doi: 10.1093/europace/euy219.
8
Efficacy and safety of non-transvenous cardioverter defibrillators in infants and young children.非经静脉心脏复律除颤器在婴幼儿中的有效性和安全性。
J Interv Card Electrophysiol. 2019 Mar;54(2):151-159. doi: 10.1007/s10840-018-0451-y. Epub 2018 Sep 25.
9
Long-term outcome of epicardial implantable cardioverter-defibrillator systems in children: results justify its preference in paediatric patients.心外膜植入式心律转复除颤器系统在儿童中的长期疗效:结果证明其在儿科患者中的优势。
Europace. 2018 Sep 1;20(9):1484-1490. doi: 10.1093/europace/eux284.
10
Midterm Results of Implantable Cardioverter Defibrillators in Children and Young Adults from a Single Center in Turkey.土耳其单中心儿童和青年植入式心脏复律除颤器的中期结果
Pacing Clin Electrophysiol. 2016 Nov;39(11):1225-1239. doi: 10.1111/pace.12954. Epub 2016 Oct 28.